Development of a pharmacist-managed latent tuberculosis clinic

American Journal of Health-System Pharmacy

Volumn 66, Issue 17, 2009, Pages 1522-1523

  Last, Julie P ^a   Kozakiewicz, Janet M ^b  

^a HOSPITAL OF SAINT RAPHAEL   (United States)

^b Hospital of Saint Raphael   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ISONIAZID; PYRIDOXINE; TUBERCULIN;

ADULT; BACTERIAL TRANSMISSION; CHILD; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEALTH PROGRAM; HUMAN; LIVER FUNCTION TEST; LOWEST INCOME GROUP; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM TUBERCULOSIS; PATIENT CARE; PATIENT COMPLIANCE; PHARMACIST; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PUBLIC HEALTH SERVICE; SHORT SURVEY; THORAX RADIOGRAPHY; TREATMENT DURATION; UNSPECIFIED SIDE EFFECT;

EID: 69749126259     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.2146/ajhp090034     Document Type: Short Survey

References (6)

1. Centers for Disease Control and Prevention. The difference between latent TB infection and active disease. www.cdc.gov/tb/topic/basics/default. htm#difference (accessed 2009 Jun 26).
2. Burman WJ, Cohn DL, Rietmeijer CA et al. Noncompliance with directly observed therapy for tuberculosis. Epidemiology and effect on the outcome of treatment. Chest. 1997; 111:1168-1173 (Pubitemid 27200067)
3. American Thoracic Society. Targeted tuberculin testing and treatment of latent tuberculosis infection. MMWR Recomm Rep. 2000; 49(RR-6):1-51.
4. Coker R. Tuberculosis, non-compliance and detention for the public health. J Med Ethics. 2000; 26:157-159 (Pubitemid 30336156)
5. Tavitian SM, Spalek VH, Bailey RP. A pharmacist-managed clinic for the treatment of latent tuberculosis infection in health care workers. Am J Health-Syst Pharm. 2003; 60:1856-1861
6. Centers for Disease Control and Prevention. Treatment of latent tuberculosis infection (LTBI). www.cdc.gov/tb/publications/factsheets/treatment/ treatmentLTBI.htm (accessed 2009 Jul 21).